Clinical Trial Update: A Study of SBRT Combined With Puterizumab in Intrapulmonary Metastasis From NSCLC [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating SBRT in combination with Puterizumab for intrapulmonary metastases from non-small-cell lung cancer, with status not yet recr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Puterizumab (Puterizumab)

Snippet

Sponsor: Sir Run Run Shaw Hospital | Conditions: Non-Small-Cell Lung Cancer | Phase 2 | Status: NOT_YET_RECRUITING